Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
Incidentie van tweede primaire maligniteit bij met anti-CD38 mAb behandeld MM
sep 2023 | MM